Krebs von den Lungen-6 levels in untreated idiopathic pulmonary fibrosis.
Dingyuan JiangHuijuan XiaoRun DongJing GengBingbing XieYanhong RenHua-Ping DaiPublished in: The clinical respiratory journal (2022)
It is identified that serum KL-6 is a useful noninvasive biomarker to help improve the certainty of IPF diagnosis from other interstitial lung disease and assist evaluation of disease severity and prognosis.